{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 1.1792442, "regularMarketPrice": 0.2145, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.03, "sharesOutstanding": 334680000, "bookValue": 0.21, "fiftyDayAverage": 0.230496, "fiftyDayAverageChange": -0.01599601, "fiftyDayAverageChangePercent": -0.0693982, "twoHundredDayAverage": 0.2367075, "twoHundredDayAverageChange": -0.022207499, "twoHundredDayAverageChangePercent": -0.093818314, "marketCap": 71788856, "priceToBook": 1.0214286, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1522994400000, "priceHint": 4, "marketState": "REGULAR", "exchange": "FRA", "shortName": "BIOPORTO A/S B  DK 1", "longName": "BioPorto A/S", "messageBoardId": "finmb_11518512", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": 0.0024999976, "regularMarketTime": 1683872766, "regularMarketDayHigh": 0.2145, "regularMarketDayRange": "0.2145 - 0.2145", "regularMarketDayLow": 0.2145, "regularMarketVolume": 1000, "regularMarketPreviousClose": 0.212, "bid": 0.203, "ask": 0.233, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "DKK", "regularMarketOpen": 0.2145, "averageDailyVolume3Month": 771, "averageDailyVolume10Day": 100, "fiftyTwoWeekLowChange": 0.1073, "fiftyTwoWeekLowChangePercent": 1.0009328, "fiftyTwoWeekRange": "0.1072 - 0.38", "fiftyTwoWeekHighChange": -0.1655, "fiftyTwoWeekHighChangePercent": -0.4355263, "fiftyTwoWeekLow": 0.1072, "fiftyTwoWeekHigh": 0.38, "symbol": "2P4.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Tuborg Havnevej 15, st.", "address2": "Ground Floor", "city": "Hellerup", "zip": "2900", "country": "Denmark", "phone": "45 45 29 00 00", "fax": "45 45 29 00 01", "website": "https://bioporto.com", "industry": "Diagnostics & Research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "longBusinessSummary": "BioPorto A/S, an in-vitro diagnostics company, provides biomarker tests and tools, and antibodies for clinicians and researchers in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. The company was incorporated in 1917 and is based in Hellerup, Denmark.", "fullTimeEmployees": 32, "companyOfficers": [{"maxAge": 1, "name": "Mr. Anthony Paul Pare", "age": 59, "title": "Chief Exec. Officer", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 933653, "fmt": "933.65k", "longFmt": "933,653"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Neil Allan Goldman CPA", "age": 53, "title": "Exec. VP & CFO", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 769601, "fmt": "769.6k", "longFmt": "769,601"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Lars Otto Uttenthal", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Gry Husby Larsen", "title": "Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jennifer  Zonderman", "title": "VP of Global Marketing & US Commercialization", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Nis  Kruse", "title": "Exec. VP of Strategic Partnerships and GM of EMEA & APAC", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 2, "compensationRisk": 6, "shareHolderRightsRisk": 1, "overallRisk": 2, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}